Bumper Offer - Urjas oil Just @ Rs. 1
Clonit G is an allopathic medicine The correct dosage of Clonit G depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Clonit G is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| Adult(Male) |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Clonit G is used -
Moderate
Mild
Is the use of Clonit G safe for pregnant women?
Clonit G shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Clonit G safe during breastfeeding?
Clonit G can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Clonit G on the Kidneys?
Clonit G has very mild side effects on the kidneys.
What is the effect of Clonit G on the Liver?
Clonit G is not harmful for the liver.
What is the effect of Clonit G on the Heart?
Using Clonit G does not have any harmful effects on the heart.
Clonit G should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Clonit G unless your doctor advises you to do so -
Is this Clonit G habit forming or addictive?
No, there is no any evidence that Clonit G is addictive.
Interaction between Food and Clonit G
Taking Clonit G with food is safe.
Interaction between Alcohol and Clonit G
Due to lack of research, there is no information about the side effects of taking Clonit G with alcohol.
No, Clonit G should not be discontinued without doctors advice. You are recommended to always consult a doctor before discontinuing this medicine.
Yes, Clonit G may cause skin discoloration or color changes. It is a rare side effect of this drug. However, the exact cause behind skin discoloration is not known but it is more likely to occur if the skin is covered with a dressing after applying this drug. So you are advised to not cover your skin with a dressing after applying this drug.
Clonit G is used for the short-term treatment up to 2 weeks and if required then maximum up to 4 weeks. You are advised to use it as directed by your doctor. Do not use this medicine longer than prescribed by your doctor to avoid the unpleasant side effect.
Yes, Clonit G is safe to use, if applied in prescribed amount and duration as advised by the doctor. However, certain side effects have been associated with this drug such as skin atrophy (skin thinning), burning or stinging sensation of the skin. If you experience above-mentioned side after using this drug then inform your doctor and follow his/her instructions.
Clonit G contains clobetasol which is presumed to work by promoting the induction of inhibitory proteins (lipocortins) in the body. Lipocortins prevents the release of arachidonic acid which causes synthesis and release of certain chemicals such as histamine, leukotrienes, and prostaglandins that causes inflammation. In this way Clonit G prevents the skin inflammation which provides relief to the patient from rash, itching, and redness.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Impoyz (clobetasol propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 895
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 369-370
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-139
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 750
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Neo-Fradin (neomycin sulfate)
